Cox-2 inhibitors and fracture healing: An argument against such an effect (multiple letters)

Journal of Bone and Mineral Research

Volumn 18, Issue 3, 2003, Pages 583-

  Hochberg, Marc C ^a   Melin, Jeffrey M ^b   Reicin, Alise ^b   Einhorn, Thomas A ^c   O'Connor, J Patrick ^d  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b MERCK RESEARCH LABORATORIES   (United States)

^c BOSTON UNIVERSITY MEDICAL CENTER   (United States)

^d RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELECOXIB; CYCLOOXYGENASE 2 INHIBITOR; KETOROLAC; NONSTEROID ANTIINFLAMMATORY AGENT; PIROXICAM; PROSTAGLANDIN; ROFECOXIB;

CLINICAL TRIAL; DISEASE COURSE; DRUG CHOICE; DRUG EFFECT; DRUG RESPONSE; DRUG SAFETY; DRUG USE; FRACTURE HEALING; FRACTURE NONUNION; HUMAN; LETTER; NONHUMAN; RISK FACTOR; SPINE FUSION;

EID: 0037370752     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1359/jbmr.2003.18.3.583     Document Type: Letter

References (0)